Quinze-Vingts National Ophthalmology Hospital — Clinical Trial Site

37 Registered trials

15 Currently recruiting

Organisation

Quinze-Vingts National Ophthalmology Hospital

Location

Paris, France

Identifier

ORG-100009504

Address

28 Rue De Charenton, 75012, France

Departments

1509:Medecine Interne
Center for Rare Disease
Centre d ’Investigation Clinique 1423
Centre de maladies rares CHNO des Quinze Vingt
Centre National de Reference Maladies Rares REFERET
CIC 1423
Clinical Investigation Center
Electrophysiology unit
Internal medicine
Internal Medicine Department
Medecine Interne
Neurology
Oncopole
Ophtalmogie
ophtalmologie
Ophtalmology
Ophtalmology – Service Pr Paques
Ophtalomogy
Ophthalmology
Service d'onco-ophtalmologie
Service d’ophtalmologie
Service de Médecine Interne

Clinical trials at this site (37)

Search interface

A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with… Not authorised

2024-515199-10-00 Retinitis Pigmentosa 4
SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre… Pending

2023-509713-37-00 Patient with severe eye chemical burns 4
Evaluation of a therapeutic de-eScalation strategy based on therapeutic drug MOnitOring in chronic non-infectious uveitis Treated witH adali… Pending

2023-509733-39-00 noninfectious uveitis 6
An Open-Label, Single-Arm, 3-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease Pending

2025-522460-33-00 Stargardt Disease 5
Darovasertib before Surgery or Radiation Therapy to Treat Early-stage Eye Cancer (Uveal Melanoma) Recruiting

2025-522387-32-00 Uveal Melanoma 5 2026-04-10
A trial to investigate teprotumumab mg/ml subcutaneous administration compared with placebo in male and female adult participants with moder… Recruiting

2024-515702-63-00 Moderate-to-Severe Active Thyroid Eye Disease 5 2025-02-20
A dose-ranging randomized, open-label study evaluating the effect of bilateral intravitreal injection of GS010 at two dose levels on visual … Recruiting

2025-523339-20-00 Leber Hereditary Optic Neuropathy due to mutations in t 4 2026-01-20
Study to Assess the Injection Burden, Safety, Efficacy, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec (ABBV-RGX-314) … Recruiting

2024-512298-28-00 Neovascular age-related macular degeneration 11 2025-12-18
Phase IIIb Study of 36-Week Refill Exchanges of Port Delivery System with Ranibizumab in nAMD Recruiting

2024-516924-32-00 Neovascular Age-Related Macular Degeneration (nAMD) 5 2025-10-17
A Phase I/IIa Clinical Trial to Assess the Safety, Tolerability, and Efficacy of a Single Intravitreal Injection of SPVN20 Gene Therapy in P… Recruiting

2025-520665-47-00 End-stage rod-cone dystrophy 1 2025-10-08
A Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retiniti… Recruiting

2024-515199-10-01 Retinitis Pigmentosa 4 2025-09-29
A Double-Masked, Randomized, Placebo-Controlled, Paired Eye Study to Evaluate the Efficacy, Safety and Tolerability of Sepofarsen in Subject… Recruiting

2024-518378-14-00 Leber congenital amaurosis (LCA) 5 2025-07-11
Immediate corticosteroid therapy and rituximab to prevent generalization in ocular myasthenia gravis: a PROBE-type multicenter, open-label, … Recruiting

2023-506656-24-00 Myasthenia gravis 5 2025-02-12
“Randomized controlled multicenter study comparing efficacy and safety of adalimumab to that of mycophenolate mofetil in steroid dependent n… Recruiting

2023-505112-38-00 recently active non-infectious intermediate, posterior, 11 2024-07-01
UVB: treatment of UVeitis in Behçet’s diseases with biologic Recruiting

2024-513371-41-00 Severe uveitis of Behçet’s disease 4 2024-04-25
A RANDOMIZED DOUBLE BLIND, PLACEBO-CONTROLLED NATIONAL MULTICENTER PHASE 3 TRIAL TO EVALUATE THE EFFICACY OF AZATHIOPRINE FOR THE PREVENTION… Recruiting

2022-500520-30-00 neurology 5 2023-03-01
LOADEX: PILOT AND PHASE 2 STUDY OF THE EFFICACY OF A TREATMENT PROTOCOL WITH DEXAMETHASONE IMPLANT LOADING DOSE IN PATIENTS WITH DIABETIC MA… Recruiting

2024-514362-39-00 Diabetic macular oedema 4 2019-12-05
Tissue replacement in RPE related dystrophies Recruiting

2024-513662-18-00 Patients with retinitis pigmentosa due to monogenic mut 7 2019-08-19
A Phase 1/2a gene therapy clinical trial in Retinitis Pigmentosa subjects. Recruiting

2024-516059-42-00 Retinitis Pigmentosa 9 2017-12-22
A study to assess efficacy and safety of efgartigimod PH20 SC in adults with ocular myasthenia gravis Ended

2024-514133-38-00 Ocular Myasthenia Gravis 5 2025-03-19
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Participants with Dry Age-Related Macular Degeneration… Ended

2024-515022-88-00 Dry Age-Related Macular Degeneration (AMD) with geograp 5 2025-03-03
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants with Moderate-to-Severe Thy… Ended

2023-503669-50-00 Moderate-to-Severe Thyroid Eye Disease 5 2023-12-27
Clinical study to evaluate the safety and tolerability of SPVN06 (novel gene therapy) in a subset of patients with rod cone dystrophy (RCD). Ended

2022-501250-12-01 Inherited retinal dystrophies 7 2023-03-17
Long Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defec… Ended

2024-511411-25-00 X-Linked Retinitis Pigmentosa caused by mutations in th 5 2022-08-25